204 related articles for article (PubMed ID: 35739317)
1. Ceramide-rich microdomains facilitate nuclear envelope budding for non-conventional exosome formation.
Arya SB; Chen S; Jordan-Javed F; Parent CA
Nat Cell Biol; 2022 Jul; 24(7):1019-1028. PubMed ID: 35739317
[TBL] [Abstract][Full Text] [Related]
2. Exosomes mediate LTB4 release during neutrophil chemotaxis.
Majumdar R; Tavakoli Tameh A; Arya SB; Parent CA
PLoS Biol; 2021 Jul; 19(7):e3001271. PubMed ID: 34232954
[TBL] [Abstract][Full Text] [Related]
3. Exosomes Mediate LTB4 Release during Neutrophil Chemotaxis.
Majumdar R; Tavakoli Tameh A; Parent CA
PLoS Biol; 2016 Jan; 14(1):e1002336. PubMed ID: 26741884
[TBL] [Abstract][Full Text] [Related]
4. Modeling neutrophil migration in dynamic chemoattractant gradients: assessing the role of exosomes during signal relay.
Szatmary AC; Nossal R; Parent CA; Majumdar R
Mol Biol Cell; 2017 Nov; 28(23):3457-3470. PubMed ID: 28954858
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandins inhibit 5-lipoxygenase-activating protein expression and leukotriene B4 production from dendritic cells via an IL-10-dependent mechanism.
Harizi H; Juzan M; Moreau JF; Gualde N
J Immunol; 2003 Jan; 170(1):139-46. PubMed ID: 12496393
[TBL] [Abstract][Full Text] [Related]
6. Hypercholesterolemia increases the production of leukotriene B4 in neutrophils by enhancing the nuclear localization of 5-lipoxygenase.
Lai XF; Qin HD; Guo LL; Luo ZG; Chang J; Qin CC
Cell Physiol Biochem; 2014; 34(5):1723-32. PubMed ID: 25428728
[TBL] [Abstract][Full Text] [Related]
7. Two- and three-color STORM analysis reveals higher-order assembly of leukotriene synthetic complexes on the nuclear envelope of murine neutrophils.
Schmider AB; Bauer NC; Sunwoo H; Godin MD; Ellis GE; Lee JT; Nigrovic PA; Soberman RJ
J Biol Chem; 2020 Apr; 295(17):5761-5770. PubMed ID: 32152223
[TBL] [Abstract][Full Text] [Related]
8. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
9. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
McDonald PP; McColl SR; Braquet P; Borgeat P
Br J Pharmacol; 1994 Mar; 111(3):852-60. PubMed ID: 8019762
[TBL] [Abstract][Full Text] [Related]
10. Phospholipase A2 activation in human neutrophils requires influx of extracellular Ca2+ and leukotriene B4.
Reddy S; Bose R; Rao GH; Murthy M
Am J Physiol; 1995 Jan; 268(1 Pt 1):C138-46. PubMed ID: 7840141
[TBL] [Abstract][Full Text] [Related]
11. Selective localization of recognition complexes for leukotriene B4 and formyl-Met-Leu-Phe within lipid raft microdomains of human polymorphonuclear neutrophils.
Sitrin RG; Emery SL; Sassanella TM; Blackwood RA; Petty HR
J Immunol; 2006 Dec; 177(11):8177-84. PubMed ID: 17114494
[TBL] [Abstract][Full Text] [Related]
12. Acute and chronic suppression of leukotriene B4 synthesis ex vivo in neutrophils from patients with rheumatoid arthritis beginning treatment with methotrexate.
Sperling RI; Benincaso AI; Anderson RJ; Coblyn JS; Austen KF; Weinblatt ME
Arthritis Rheum; 1992 Apr; 35(4):376-84. PubMed ID: 1314609
[TBL] [Abstract][Full Text] [Related]
13. Activated LTB4 pathway in muscle tissue of patients with polymyositis or dermatomyositis.
Loell I; Alemo Munters L; Pandya J; Zong M; Alexanderson H; Fasth AE; Ståhl Hallengren C; Rådmark O; Lundberg IE; Jakobsson PJ; Korotkova M
Ann Rheum Dis; 2013 Feb; 72(2):293-9. PubMed ID: 22736094
[TBL] [Abstract][Full Text] [Related]
14. The leukotriene B
Deng B; Lin Y; Ma S; Zheng Y; Yang X; Li B; Yu W; Xu Q; Liu T; Hao C; He R; Ding F
Kidney Int; 2017 Jul; 92(1):89-100. PubMed ID: 28318626
[TBL] [Abstract][Full Text] [Related]
15. 5-lipoxygenase and 5-lipoxygenase-activating protein are localized in the nuclear envelope of activated human leukocytes.
Woods JW; Evans JF; Ethier D; Scott S; Vickers PJ; Hearn L; Heibein JA; Charleson S; Singer II
J Exp Med; 1993 Dec; 178(6):1935-46. PubMed ID: 8245774
[TBL] [Abstract][Full Text] [Related]
16. Nuclear localization of 5-lipoxygenase as a determinant of leukotriene B4 synthetic capacity.
Luo M; Jones SM; Peters-Golden M; Brock TG
Proc Natl Acad Sci U S A; 2003 Oct; 100(21):12165-70. PubMed ID: 14530386
[TBL] [Abstract][Full Text] [Related]
17. Leukotriene b4 and its metabolites prime the neutrophil oxidase and induce proinflammatory activation of human pulmonary microvascular endothelial cells.
Eun JC; Moore EE; Banerjee A; Kelher MR; Khan SY; Elzi DJ; McLaughlin NJ; Silliman CC
Shock; 2011 Mar; 35(3):240-4. PubMed ID: 20926984
[TBL] [Abstract][Full Text] [Related]
18. The role of the LTB4-BLT1 axis in health and disease.
He R; Chen Y; Cai Q
Pharmacol Res; 2020 Aug; 158():104857. PubMed ID: 32439596
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis.
Sánchez-Galán E; Gómez-Hernández A; Vidal C; Martín-Ventura JL; Blanco-Colio LM; Muñoz-García B; Ortega L; Egido J; Tuñón J
Cardiovasc Res; 2009 Jan; 81(1):216-25. PubMed ID: 18852255
[TBL] [Abstract][Full Text] [Related]
20. Activation of the human neutrophil 5-lipoxygenase by leukotriene B4.
McDonald PP; McColl SR; Naccache PH; Borgeat P
Br J Pharmacol; 1992 Sep; 107(1):226-32. PubMed ID: 1330161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
